Acquired 5‐aza resistance in testicular cancer cells is associated with genome‐wide alterations in levels of polycomb target genes, H3K27me3, H2AUbK119, and DNMT3B that is in an opposing manner compared to cisplatin resistant cells. The gene discussed is DNMT3B; the disease is testicular cancer.